Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.
作者信息
Heinemann Klaas, Heinemann Lothar A J
机构信息
ZEG - Berlin, Berlin, Germany.
出版信息
J Fam Plann Reprod Health Care. 2011 Jul;37(3):132-5. doi: 10.1136/jfprhc-2011-14524. Epub 2011 Jun 9.
PMID:21659330
Abstract
摘要
相似文献
1
Comparative risks of venous thromboembolism among users of oral contraceptives containing drospirenone and levonorgestrel.
J Fam Plann Reprod Health Care. 2011 Jul;37(3):132-5. doi: 10.1136/jfprhc-2011-14524. Epub 2011 Jun 9.
2
Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
J Fam Plann Reprod Health Care. 2010 Jul;36(3):123-9. doi: 10.1783/147118910791749416.
3
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
BMJ. 2011 Oct 25;343:d6423. doi: 10.1136/bmj.d6423.
4
Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
Contraception. 2014 Apr;89(4):253-63. doi: 10.1016/j.contraception.2014.01.023. Epub 2014 Feb 4.
5
Drospirenone and VTE.
J Fam Plann Reprod Health Care. 2010 Jan;36(1):44. doi: 10.1783/147118910790291127.
6
ACOG Committee Opinion Number 540: Risk of venous thromboembolism among users of drospirenone-containing oral contraceptive pills.
Obstet Gynecol. 2012 Nov;120(5):1239-42. doi: 10.1097/aog.0b013e318277c93b.
7
8
Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters.
Drug Saf. 2017 Jul;40(7):583-596. doi: 10.1007/s40264-017-0525-2.
9
Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database.
BMJ. 2011 Apr 21;342:d2139. doi: 10.1136/bmj.d2139.
10
Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives.
Contraception. 2016 May;93(5):378-85. doi: 10.1016/j.contraception.2016.01.012. Epub 2016 Jan 26.
引用本文的文献
1
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
PLoS One. 2017 Jul 21;12(7):e0182045. doi: 10.1371/journal.pone.0182045. eCollection 2017.
2
Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
BMJ. 2015 May 26;350:h2135. doi: 10.1136/bmj.h2135.
Zotero 插件